Patent Strategies in Your First Few Years of a New Business
Introduction A new business that plans to bring a new and innovative product or service to market ought to address patents right from the first
July 23, 2015
No Comments
Category: Patents
Breaking the Fall Off the Patent Cliff: Can Developing Countries Help Big Pharma?
Expiring patents are expected to contribute billions of dollars towards the loss of revenue of drug manufacturers in the years to come. To save itself from
May 21, 2015
No Comments
Paying for Delay: Old School Lawyering Meets Compound Interest
Compound interest ought to be the rule rather than the exception in calculating prejudgment interest in litigation involving commercial businesses. It is welcoming to see
April 14, 2015
No Comments
Virotech Patents, Viropiracy, and Viral Sovereignty
INTRODUCTION Access to medicines goes hand in hand with the protection of intellectual property rights. At a time when the United States is undertaking large-scale
April 1, 2015
No Comments
An Unexpected Infringement: There and Back Again
On March 16, 2015, Justice Barnes held that AstraZeneca’s Patent No 1,292,693 (“’693 Patent”), a formulation patent for omeprazole, was valid and infringed by Apotex
March 31, 2015
1 Comment
A Dose of Consistency: SCOTUS Settles the Controversy in Teva v Sandoz for Patent Litigation
In Teva Pharmaceuticals USA Inc v Sandoz Inc, a patent infringement case evolved into an opportunity for the Supreme Court of the United States (SCOTUS)
March 10, 2015
No Comments